SCHEMBL12697372

SCHEMBL12697372

C/N=c1\ccc2c(-c3ccccc3C(=O)O)c3ccc(NC)cc3oc-2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCB1 P08183 1/20 0.45
▸ USP2 O75604 5/20 0.43
▸ ATM Q13315 2/20 0.43
▸ CFTR P13569 1/20 0.43
▸ PAX8 Q06710 1/20 0.43
▸ GOPC Q9HD26 1/20 0.43
▸ FTO Q9C0B1 2/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ POLB P06746 3/20 0.40
▸ KDM4E B2RXH2 2/20 0.40
▸ DNASE1L3 Q13609 1/20 0.40
▸ PRMT1 Q99873 1/20 0.40
▸ CA9 Q16790 8/20 0.39
▸ CA1 P00915 7/20 0.39
▸ CA2 P00918 7/20 0.39
▸ MEN1 O00255 3/20 0.38
▸ KMT2A Q03164 3/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ THRB P10828 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL609855 1.00 ABCB1 (0.45) ABCB1USP2ATMCFTRPAX8
SCHEMBL6056016 1.00 ABCB1 (0.45) ABCB1USP2ATMCFTRPAX8
Perchlorate SCHEMBL29692775 0.95 ABCB1 (0.42) ABCB1USP2ATMCFTRPAX8
Perchlorate SCHEMBL5606714 0.95 ABCB1 (0.42) ABCB1USP2ATMCFTRPAX8
Perchlorate SCHEMBL5606712 0.95 ABCB1 (0.42) ABCB1USP2ATMCFTRPAX8
SCHEMBL21878562 0.88 USP2 (0.56) ABCB1USP2ATMCFTRPAX8
SCHEMBL21878561 0.88 USP2 (0.56) ABCB1USP2ATMCFTRPAX8
SCHEMBL10145544 0.86 USP2 (0.55) ABCB1USP2ATMCFTRPAX8
SCHEMBL5606715 0.86 ABCB1 (0.47) ABCB1USP2ATMCFTRPAX8
SCHEMBL14350757 0.85 ABCB1 (0.61) ABCB1USP2ATMCFTRPAX8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210309913-A1 COMPOSITION FOR CORRECTING COLOR BLINDNESS NITTO DENKO CORPORATION (JP) 2021-10-07 — — US disclosed
US-10752833-B2 Optical element for correcting color blindness NITTO DENKO CORPORATION (JP) 2020-08-25 — — US disclosed
US-10738068-B2 Organic/inorganic hybrid nanoparticulates made from iron carboxylates Centre National de la Recherche Scientifique—CNRS (FR) 2020-08-11 — — US disclosed
US-20190194535-A1 OPTICAL ELEMENT FOR CORRECTING COLOR BLINDNESS NITTO DENKO CORPORATION (JP) 2019-06-27 — — US disclosed
US-20170088771-A1 OPTICAL ELEMENT FOR CORRECTING COLOR BLINDNESS NITTO DENKO CORPORATION (JP) 2017-03-30 — — US disclosed
US-9574067-B2 Optical element for correcting color blindness NITTO DENKO CORPORATION (JP) 2017-02-21 — — US disclosed
EP-2739997-B1 OPTICAL ELEMENT FOR CORRECTING COLOR BLINDNESS NITTO DENKO CORP (JP) 2016-06-08 — — EP disclosed
US-9022562-B2 Optical element for correcting color blindness NITTO DENKO CORPORATION (JP) 2015-05-05 — — US disclosed
US-20150098056-A1 Optical Element for Correcting Color Blindness NITTO DENKO CORPORATION (JP) 2015-04-09 — — US disclosed
US-8963104-B2 Optical element for correcting color blindness NITTO DENKO CORPORATION (JP) 2015-02-24 — — US disclosed
US-20080076119-A9 Composite organic inorganic nanoclusters SUN LEI 2008-03-27 — — US disclosed
US-7311767-B2 Forming a salt of a liquid phase change ink carrier of stearyl stearamide, an amine substituted Xanthene, acridine, anthracene or thioxanthene chromogen, and a metal salt capable of forming a compound with two chromogens XEROX CORPORATION (US) 2007-12-25 — — US disclosed
US-20070279626-A9 Multiplexed detection of analytes in fluid solution SUN LEI 2007-12-06 — — US disclosed
US-20070279626-A9 Multiplexed detection of analytes in fluid solution SUN LEI 2007-12-06 — — US disclosed
US-7301025-B2 N-(2-(2-(alkyl[carbamoyl, carbonyloxy or ureido]alkyl)pyridinium)-5-(carboxy or sulfo)phenyl-8-((2-(N-alkyl[carbamoyl or ureido]alkyl)pyridinyl) xanthene ligands complexed with a metal or metal-containing moiety; magenta dye with improved heat resistance; hot melts or phase change inks XEROX CORPORATION (US) 2007-11-27 — — US disclosed
US-7301025-B2 N-(2-(2-(alkyl[carbamoyl, carbonyloxy or ureido]alkyl)pyridinium)-5-(carboxy or sulfo)phenyl-8-((2-(N-alkyl[carbamoyl or ureido]alkyl)pyridinyl) xanthene ligands complexed with a metal or metal-containing moiety; magenta dye with improved heat resistance; hot melts or phase change inks XEROX CORPORATION (US) 2007-11-27 — — US disclosed
US-20070048797-A1 Composite organic inorganic nanoclusters as carriers and identifiers of tester molecules SU XING 2007-03-01 — — US disclosed
US-20070048797-A1 Composite organic inorganic nanoclusters as carriers and identifiers of tester molecules SU XING 2007-03-01 — — US disclosed
US-7176317-B2 Colorant compounds XEROX CORPORATION (US) 2007-02-13 — — US disclosed
US-7176317-B2 Colorant compounds XEROX CORPORATION (US) 2007-02-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10738068-B2 Organic/inorganic hybrid nanoparticulates made from iron carboxylates SLC40A1, FECH, FTH1 ABCB1 825/4885USP2 2600/4885ATM 4633/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback